Evaluating the efficacy of commercial Sela tea- high blood and Sela tea-blood sugar in combination with antihypertensive and anti-diabetic drugs: an in vitro study
- 1African Medicines Innovations and Technologies Development (AMITD), Department of Pharmacology, Faculty of Health Sciences, University of the Free State
Abstract
Background Sela Tea - High Blood (SHB) and Sela Tea - Blood Sugar (SBS) are brands made from traditional herbal medicine for lowering blood pressure and blood sugar, respectively. However, there are no reports supporting the therapeutic claims or concerning the efficacy when concomitantly use with prescription antihypertensive and antidiabetic drugs. The study aimed to evaluate the in vitro antihypertensive and antidiabetic potential of these teas and their combined effects with prescription drugs. Method Human embryonic kidney and Chang liver cells were used to assess the cytotoxicity effects of tea extracts. SHB was tested on angiotensin-converting enzyme (ACE) and renin inhibition while SBS was tested on α-amylase and α-glucosidase inhibition. A fixed dose combination design was used to evaluate the combined effects of teas and standard drugs namely, aliskiren for renin inhibition, lisinopril for ACE inhibition, and acarbose for α-amylase and α-glucosidase inhibition. The IC₅₀ concentration of the tea extract was used as fixed extract concentration and was then combined with varying concentrations of the drug. Conversely, the IC₅₀ concentration of the drug was used as the fixed drug concentration and was then combined with varying concentrations of the tea extract. Results SHB and SBS showed no cytotoxicity effects. SHB inhibited ACE and renin activities with IC50 values of 247.60 and 28.38 µg/mL respectively. SBS inhibited α-amylase and α-glucosidase with IC50 values of 1974.00 and 4.59 µg/mL respectively. The combination of the IC₅₀ values of SHB or SBS with varying concentrations of lisinopril, aliskiren, or acarbose, as well as the combination of the IC₅₀ values of these drugs with varying concentrations of SHB or SBS, resulted in significantly greater enzyme inhibition than that observed with the corresponding drug or Sela tea extract alone. Conclusion The study highlights the potential of SHB and SBS to inhibit the targeted enzymes (ACE, renin, α-amylase, and α-glucosidase) and to enhance the inhibitory effects of the selected drugs. Sela tea may therefore provide complementary effects when used alongside these drugs. However, further studies are needed to confirm this hypothesis.
Related
- The efficacy and safety of combining different commercial Chinese polyherbal preparations with conventional Western drugs in the treatment of diabetic osteoporosis: a network meta-analysis
- Improvement of Erectile Function After Switching From Valsartan to Olmesartan Within a Fixed‐Dose Antihypertensive Combination: A Case Report
- A Transparent Rule-Based Decision-Support Prototype for Diabetic Menu Planning and Meal-Combination Optimization: Development and Computational Evaluation
- Amelioration of chronic inflammation, insulin resistance, and gut microbiota homeostasis by a combination of Bifidobacterium, Lactobacillus, Enterococcus, and Bacillus in obese type 2 diabetic mice
- Evaluating the safety of glucagon-like peptide-1 agonist use in non-diabetic overweight patients undergoing shoulder arthroplasty
BibTeX
@article{matsabisa2026evaluating,
title = {{Evaluating the efficacy of commercial Sela tea- high blood and Sela tea-blood sugar in combination with antihypertensive and anti-diabetic drugs: an in vitro study}},
author = {Motlalepula Gilbert Matsabisa and Sthabiso Iminathi Mthethwa and Nqobile Vanessa Hadebe and Viviane Laure Ngoungoure Ndam and Dany Joël Ngoumen Ngassa},
journal = {Clinical Phytoscience},
year = {2026},
month = oct,
doi = {10.1186/s40816-026-00446-0},
url = {https://doi.org/10.1186/s40816-026-00446-0},
note = {CC BY},
}
RIS
TY - JOUR
TI - Evaluating the efficacy of commercial Sela tea- high blood and Sela tea-blood sugar in combination with antihypertensive and anti-diabetic drugs: an in vitro study
AU - Motlalepula Gilbert Matsabisa
AU - Sthabiso Iminathi Mthethwa
AU - Nqobile Vanessa Hadebe
AU - Viviane Laure Ngoungoure Ndam
AU - Dany Joël Ngoumen Ngassa
PY - 2026
DA - 2026/10/25
JO - Clinical Phytoscience
DO - 10.1186/s40816-026-00446-0
UR - https://doi.org/10.1186/s40816-026-00446-0
AB - Background Sela Tea - High Blood (SHB) and Sela Tea - Blood Sugar (SBS) are brands made from traditional herbal medicine for lowering blood pressure and blood sugar, respectively. However, there are no reports supporting the therapeutic claims or concerning the efficacy when concomitantly use with prescription antihypertensive and antidiabetic drugs. The study aimed to evaluate the in vitro antihypertensive and antidiabetic potential of these teas and their combined effects with prescription drugs. Method Human embryonic kidney and Chang liver cells were used to assess the cytotoxicity effects of tea extracts. SHB was tested on angiotensin-converting enzyme (ACE) and renin inhibition while SBS was tested on α-amylase and α-glucosidase inhibition. A fixed dose combination design was used to evaluate the combined effects of teas and standard drugs namely, aliskiren for renin inhibition, lisinopril for ACE inhibition, and acarbose for α-amylase and α-glucosidase inhibition. The IC₅₀ concentration of the tea extract was used as fixed extract concentration and was then combined with varying concentrations of the drug. Conversely, the IC₅₀ concentration of the drug was used as the fixed drug concentration and was then combined with varying concentrations of the tea extract. Results SHB and SBS showed no cytotoxicity effects. SHB inhibited ACE and renin activities with IC50 values of 247.60 and 28.38 µg/mL respectively. SBS inhibited α-amylase and α-glucosidase with IC50 values of 1974.00 and 4.59 µg/mL respectively. The combination of the IC₅₀ values of SHB or SBS with varying concentrations of lisinopril, aliskiren, or acarbose, as well as the combination of the IC₅₀ values of these drugs with varying concentrations of SHB or SBS, resulted in significantly greater enzyme inhibition than that observed with the corresponding drug or Sela tea extract alone. Conclusion The study highlights the potential of SHB and SBS to inhibit the targeted enzymes (ACE, renin, α-amylase, and α-glucosidase) and to enhance the inhibitory effects of the selected drugs. Sela tea may therefore provide complementary effects when used alongside these drugs. However, further studies are needed to confirm this hypothesis.
SN - 2199-1197
ER -